dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Urreta-Barallobre, Iratxe |
dc.contributor.author | Ubeda Carrillo, Marimar |
dc.contributor.author | Osorio Sánchez, Dimelza |
dc.contributor.author | Lora, David |
dc.contributor.author | Oristrell Santamaria, Gerard |
dc.contributor.author | Rodenas Alesina, Eduard |
dc.contributor.author | Ballesteros Silva, Monica Patricia |
dc.contributor.author | Ribera Sole, Aida |
dc.contributor.author | Ferreira González, Ignacio |
dc.contributor.author | Marsal Mora, Josep Ramon |
dc.contributor.author | Lumbreras, Blanca |
dc.date.accessioned | 2023-01-30T08:38:08Z |
dc.date.available | 2023-01-30T08:38:08Z |
dc.date.issued | 2022-12-21 |
dc.identifier.citation | Marsal JR, Urreta-Barallobre I, Ubeda-Carrillo M, Osorio D, Lumbreras B, Lora D, et al. Sample size requirement in trials that use the composite endpoint major adverse cardiovascular events (MACE): new insights. Trials. 2022 Dec 21;23:1037. |
dc.identifier.issn | 1745-6215 |
dc.identifier.uri | https://hdl.handle.net/11351/8930 |
dc.description | Punts finals compostos; Correlació, Grandària de la mostra |
dc.description.sponsorship | Intramural CIBER-ESP PR22 from the Center for Biomedical Research in Epidemiology and Public Health Network (CIBERESP). |
dc.language.iso | eng |
dc.publisher | BMC |
dc.relation.ispartofseries | Trials;23 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Infart de miocardi - Diagnòstic |
dc.subject.mesh | Myocardial Infarction |
dc.subject.mesh | Sample Size |
dc.title | Sample size requirement in trials that use the composite endpoint major adverse cardiovascular events (MACE): new insights |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1186/s13063-022-06977-4 |
dc.subject.decs | infarto de miocardio |
dc.subject.decs | tamaño de la muestra |
dc.relation.publishversion | https://doi.org/10.1186/s13063-022-06977-4 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Marsal JR, Ribera A, Ferreira-González I] Grup de Recerca de Malalties Cardiovasculars, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBER Epidemiology and Public Health, Madrid, Spain. [Urreta-Barallobre I] CIBER Epidemiology and Public Health, Madrid, Spain. Biodonostia Health Research Institute, Clinical Epidemiology, San Sebastián, Spain. Osakidetza Basque Health Service, Donostialdea Integrated Health Organisation, Donostia University Hospital, Clinical Epidemiology Unit, San Sebastián, Spain. [Ubeda-Carrillo M] Osakidetza Basque Health Service, Donostialdea Integrated Health Organisation, Donostia University Hospital, Library Service, San Sebastián, Spain. [Osorio D, Ballesteros M] CIBER Epidemiology and Public Health, Madrid, Spain. Grup de Recerca d’Epidemiologia i Salut Pública, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Lumbreras B] CIBER Epidemiology and Public Health, Madrid, Spain. Public Health Department, Miguel Hernandez University, Alicante, Spain. [Lora D] CIBER Epidemiology and Public Health, Madrid, Spain. Health Research Institute Hospital 12 de Octubre (imas12), Madrid, Spain. Statistical Studies Department, Universidad Complutense de Madrid (UCM), Madrid, Spain. [Oristrell G] Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. CIBER Cadiovascular Diseases, Madrid, Spain. [Ródenas-Alesina E] Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 36539800 |
dc.identifier.wos | 000901723700004 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |